|
Mechanismfactor Xa inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.IT |
First Approval Date01 Jan 1993 |
100 Clinical Results associated with AY Pharmaceuticals Co., Ltd.
0 Patents (Medical) associated with AY Pharmaceuticals Co., Ltd.
100 Deals associated with AY Pharmaceuticals Co., Ltd.
100 Translational Medicine associated with AY Pharmaceuticals Co., Ltd.